Jean-Sébastien Frenel

ScholarGPS® ID: 76267283600755

Affiliation

Institut National de la Santé et de la Recherche Médicale, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

195

Predicted Citations

3,522

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature (journal article) Aubert, Marine \| Mathiot, Laurent \| Vegas, Hélène \| Ouldamer, Lobna \| Linassier, Claude \| Augereau, Paule \| Bocquet, François \| Frenel, Jean-Sébastien \| Cancel, Mathilde The Oncologist, volume 29, issue 7, pages e910-e917 (2024). 10.1093/oncolo/oyae093 Cite \| Source
Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial. (journal article) Classe, Jean-Marc \| Campion, Loic \| Lecuru, Fabrice \| Vergote, Ignace \| Jankowski, Clémentine \| Wernert, Romuald \| Pomel, Christophe \| Houvenaeghel, Gilles \| Dupre, Pierre-Francois \| Mathevet, Patrice \| ... \| Loaec, Cecile Journal of Clinical Oncology, volume 42, issue 17_suppl, pages LBA5505-LBA5505 (2024). 10.1200/JCO.2024.42.17_suppl.LBA5505 Cited by (1) \| Cite \| Source
53P Description of BRCA mutated high-grade ovarian cancer demonstrating primary resistance to first-line platinum in the French national multicenter ESME database (journal article) Leary, A. \| Fouquier, A. \| Ray-Coquard, I.L. \| Rodrigues, M.J. \| Frenel, J-S. \| Sabatier, R. \| Petit, T. \| Guillemet, C. \| de la Motte Rouge, T. \| Colombo, P-E. \| ... \| Camilleri, G.M. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103560 Cite \| Source
Artificial intelligence to predict homologous recombination deficiency in ovarian cancer from whole-slide histopathological images. (journal article) Frenel, Jean-Sebastien \| Bossard, Céline \| Rynkiewicz, Joseph \| Thomas, Florian \| Salhi, Yahia \| Salhi, Sanae \| Chetritt, Jérôme Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5578-5578 (2024). 10.1200/JCO.2024.42.16_suppl.5578 Cite \| Source
Survival outcome prediction of breast carcinomas on whole-slide histopathology images using deep learning. (journal article) Paul, Julian \| Bossard, Céline \| Rynkiewicz, Joseph \| Molinié, Florence \| Salhi, Sanae \| Frenel, Jean-Sebastien \| Salhi, Yahia \| Chetritt, Jérôme Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1070-1070 (2024). 10.1200/JCO.2024.42.16_suppl.1070 Cite \| Source
Prediction of pathological response to neo-adjuvant chemotherapy using texture parameters of initial 18-FDG PET/CT in estrogen receptor positive/Her2 negative (ER+/HER2-) early breast cancer (eBC). (journal article) Corda, Hugo \| Lasla, Hamza \| Guillerminet, Camille \| Lacombe, Marie \| Girault, Sylvie \| Campone, Mario \| Frenel, Jean-Sebastien \| Jézéquel, Pascal \| Patsouris, Anne Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e12567-e12567 (2024). 10.1200/JCO.2024.42.16_suppl.e12567 Cite \| Source
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study (journal article) Zhou, Ke \| Robert, Marie \| Seegers, Valérie \| Blanc-Lapierre, Audrey \| Savouroux, Stéphane \| Bigot, Frédéric \| Frenel, Jean-Sébastien \| Campone, Mario \| Conroy, Thierry \| Penault-Llorca, Frédérique \| ... \| Bellanger, Martine M. PLOS ONE, volume 19, issue 5, pages e0304556- (2024). 10.1371/journal.pone.0304556 Cite \| Source
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype (journal article) Jézéquel, Pascal \| Lasla, Hamza \| Gouraud, Wilfried \| Basseville, Agnès \| Michel, Bertrand \| Frenel, Jean-Sébastien \| Juin, Philippe P. \| Ben Azzouz, Fadoua \| Campone, Mario Breast Cancer (2024). 10.1007/s12282-024-01597-z Cite \| Source
258P Real-world (rw) outcomes in patients (pts) with hormone receptor-positive and human epidermal growth factor receptor-2-negative (HR+/HER2-) metastatic breast cancer (mBC) treated with chemotherapy (CT) in France (journal article) Campone, M. \| Frenel, J-S. \| Kiver, V.I.I. \| Woeckel, A. \| Kerscher, A.G. \| Krebs, M. \| Leal, C.S. \| Saglimbene, V.M. \| Rehnquist, M.K. \| Sadetsky, N. \| ... \| Bocquet, F. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103279 Cite \| Source
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients (journal article) Bouvarel, Barnabe \| Colomban, Oliver \| Frenel, Jean-Sebastien \| Loaec, Cécile \| Bourgin, Charlotte \| Berton, Dominique \| Freyer, Gilles \| You, Benoit \| Classe, Jean-Marc International Journal of Gynecologic Cancer, volume 34, issue 4, pages 574-580 (2024). 10.1136/ijgc-2023-004872 Cited by (5) \| Cite \| Source
521 Safety and efficacy of Durvalumab (D) + Tremelimumab (T) + Metronomic Oral Vinorelbine (MOV) in patients with recurrent/metastatic cervical cancer (RMCC) in the MOVIE trial (conference) Frenel, Jean-Sebastien \| Mathiot, Laurent \| Bocorman, Edith \| Hervieu, Alice \| Coquan, Elodie \| Rouge, Thibault De La Motte \| Saada-Bouzid, Esma \| Sabatier, Renaud \| Lavaud, Pernelle \| Legrand, François \| ... \| Goncalves, Anthony ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.14 Cite \| Source
État des lieux des résultats en termes de survie de la CHIP en primo-traitement et en récidive dans le cancer épithélial de l’ovaire (journal article) Classe, Jean-Marc \| Frenel, Jean-Sébastien \| Berton, Dominique \| Gladieff, Laurence \| Ferron, Gwenaël \| Lecuru, Fabrice \| Bourgin, Charlotte \| Narducci, Fabrice \| Loaec, Cécile Bulletin du Cancer, volume 111, issue 3, pages 261-266 (2024). 10.1016/j.bulcan.2023.01.019 Cite \| Source
62P Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed glioblastoma multiforme: PAZOGLIO trial (journal article) Saada, E.B. \| Gal, J. \| Frenel, J-S. \| Augereau, P. \| Bourg, V. \| Jacquinot, F. \| Gourmelon, C. \| Chateau, Y. \| Barriere, J. \| Milano, G. \| Bondiau, P-Y. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.102291 Cite \| Source
21P Mass cytometry reveals a population of exhausted CD8+ T cells associated with durvalumab/tremelimumab/vinorelbine efficacy in advanced cervical cancer (iMOVIE) (journal article) Bertucci, A. \| Maby, P. \| Rochigneux, P. \| Legrand, F. \| Cropet, C. \| Frenel, J-S. \| Le Tourneau, C. \| Hervieu, A. \| Coquan, E. \| De La Motte Rouge, T. \| ... \| Chrétien, A-S. Immuno-Oncology and Technology, volume 20 (2023). 10.1016/j.iotech.2023.100490 Cite \| Source
Association between post-operative hPG80 (circulating progastrin) detectable level and worse prognosis in glioblastoma (journal article) Doucet, L. \| Cailleteau, A. \| Vaugier, L. \| Gourmelon, C. \| Bureau, M. \| Salaud, C. \| Roualdes, V. \| Samarut, E. \| Aumont, M. \| Zenatri, M. \| ... \| Frenel, J.-S. ESMO Open, volume 8, issue 5, pages 101626- (2023). 10.1016/j.esmoop.2023.101626 Cited by (1) \| Cite \| Source
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results (journal article) Pouessel, Damien \| Ken, Soléakhéna \| Gouaze-Andersson, Valérie \| Piram, Lucie \| Mervoyer, Augustin \| Larrieu-Ciron, Delphine \| Cabarrou, Bastien \| Lusque, Amélie \| Robert, Marie \| Frenel, Jean-Sebastien \| ... \| Cohen-Jonathan Moyal, Elizabeth The Oncologist, volume 28, issue 9, pages 825-e817 (2023). 10.1093/oncolo/oyad095 Cited by (4) \| Cite \| Source
ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma (039) (journal article) Liu, Joyce \| Colombo, Nicoletta \| Oza, Amit \| Frenel, Jean-Sebastien \| Corr, Bradley \| Rubinstein, Maria \| Nevadunsky, Nicole \| Lheureux, Stephanie \| Gaba, Lydia \| Cortijo, Lucía González \| ... \| Oaknin, Ana Gynecologic Oncology, volume 176 (2023). 10.1016/j.ygyno.2023.06.512 Cited by (1) \| Cite \| Source
#201 Real world evidence (RWE) on the efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer. a multicentre, international study (conference) Frenel, Jean-Sebastien \| Guerin-Charbonnel, Catherine \| Xu-Vuillard, Alexandre \| Cheeseman, Sur \| Kubelac, Paul \| Zenatri, Morgan \| Hall, Geoffrey \| Patriciu, Patriciu \| Hanvic, Brunhilde \| Fenton, Hayley \| ... \| Bocquet, François ESGO 2023 Congress (2023) 10.1136/ijgc-2023-ESGO.534 Cite \| Source
Mammary carcinoma: Comparative oncology between small animals and humans—New therapeutic tools (journal article) Frénel, Jean‐Sébastien \| Nguyen, Frédérique Reproduction in Domestic Animals, volume 58, issue S2, pages 102-108 (2023). 10.1111/rda.14408 Cited by (2) \| Cite \| Source
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program (journal article) de Moura, Alexandre \| Vuagnat, Perrine \| Renouf, Benjamin \| Pierga, Jean-Yves \| Loirat, Delphine \| Vaflard, Pauline \| Lafayolle de la Bruyère, Charline \| Chaumard-Billotey, Natacha \| Hajjaji, Nawale \| Ladoire, Sylvain \| ... \| Bidard, François-Clément Scientific Reports, volume 13, issue 1 (2023). 10.1038/s41598-023-40569-9 Cited by (2) \| Cite \| Source